FDA approves DBA Systems mammo station
Florida-based DBA Systems has received premarket approval from the Food and Drug Administration for its film mammogram review and analysis workstation, ImagClear Mammography Review System. The product line offers several different models. The main
Florida-based DBA Systems has received premarket approval from the Food and Drug Administration for its film mammogram review and analysis workstation, ImagClear Mammography Review System.
The product line offers several different models. The main modelsthe CV 6000, Tech 5000, and VS 500are ready and available for clinical use, said Glenn Turner, DBA Systems manager of medical research and development.
Company officials said they hope to bridge the gap between film-based and filmless technology with the ImagClear system.
The ImagClear uses hardware, software, and communications technology that allow a radiologist to apply digital imaging techniques to the viewing, manipulation, and communication of film mammograms. Image capture is accomplished through the ImagClear systems film digitizer, which provides a pixel resolution of 42 microns and a gray-scale range of 16 bits to produce a minimum 4K x 5K image matrix, which is adequate for even the highest quality mammography films.
The image viewing software ImagClear uses was specifically designed to meet the demanding requirements of mammography. Images from the ImagClear Film Digitizer can be organized into studies and sessions and the system creates online reports.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
